Pub. Date:
Birkh�user Basel
Novel Inhibitors of Leukotrienes / Edition 1

Novel Inhibitors of Leukotrienes / Edition 1


View All Available Formats & Editions
Current price is , Original price is $279.99. You
Select a Purchase Option (1999)
  • purchase options
    $237.99 $279.99 Save 15% Current price is $237.99, Original price is $279.99. You Save 15%.
  • purchase options

Product Details

ISBN-13: 9783764358846
Publisher: Birkh�user Basel
Publication date: 09/24/1999
Series: Progress in Inflammation Research
Edition description: 1999
Pages: 347
Product dimensions: 6.30(w) x 9.30(h) x 1.00(d)

Table of Contents

5-Lipoxygenase.- LTC4 synthase: A key enzyme in cysteinyl leukotriene formation.- Leukotriene A4 hydrolase: A key enzyme in chemotactic leukotriene formation.- Metabolism of leukotrienes and formation of new leukotriene structures.- Receptors for cysteinyl-leukotrienes: Targets for new drugs.- Targeted disruption of 5-lipoxygenase.- Transcellular biosynthesis of leukotrienes: A unique mode of cell communication.- Physiological and pathophysiological activities of leukotrienes.- Entry rate and metabolic handling of LTC4 in the human circulation.- Genetic polymorphisms of 5-LO.- Leukotrienes and aspirin-intolerant asthma.- Leukotrienes in nocturnal asthma.- Leukotrienes and allergic asthma.- Inhibitors of leukotrienes: An overview.- The development of zafirlukast (Accolate®) and the Zeneca series of peptidyl-leukotriene receptor antagonists.- The development of zileuton (ZYFLO®) and the N-hydroxyurea class of 5-lipoxygenase inhibitors.- The development of BAY X 1005 and the Bayer series of leukotriene biosynthesis inhibitors.- The development of iralukast: A member of the Novartis series of cysteinyl leukotriene antagonists.- LTB4 receptor antagonists.- SmithKline Beecham pharmaceuticals’ cysteinyl leukotriene receptor antagonists: Pranlukast (SB 205312; Ono-1078; Onon), Pobilukast (SK&F 104353) and SK&F 106203.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews